Nexplanon 68 MG implants
Ended Awarded Last action
- Contract number
- SPE2DR26FJUV5
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,207
Award facts
- Contract value 100% obligated
- $14,207.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $14,207.40 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 68 mg Nexplanon implants. This delivery order was issued without a set-aside designation on December 12, 2025, with an ultimate completion date of January 6, 2026. Nexplanon is a subdermal contraceptive implant, representing one of the specialized pharmaceutical and medical products within DMS Pharmaceutical Group's extensive product portfolio supplied to Department of Defense healthcare facilities.
This delivery order was issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency, specifically the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The parent contract, valued at $499.9 billion with a completion date of December 31, 2036, positions DMS Pharmaceutical Group as a regional prime vendor contractor within the broader $30.3 billion PPV-G GEN V acquisition strategy. As a critical supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group leverages its established performance on numerous prior delivery orders to fulfill the diverse pharmaceutical and medical supply requirements supporting military healthcare operations worldwide.
Quick answers
Who was awarded contract SPE2DR26FJUV5?
SPE2DR26FJUV5 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 12, 2025.
How much is contract SPE2DR26FJUV5 worth?
The government has obligated $14,207 on SPE2DR26FJUV5.
Is contract SPE2DR26FJUV5 an order under another contract?
Yes. SPE2DR26FJUV5 is a delivery order under SPE2DR25D9329, an indefinite delivery contract.
Was contract SPE2DR26FJUV5 competed?
The extent of competition for SPE2DR26FJUV5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award